PeptideStack
5.2kquestions
20kanswers
220users

What is "food noise" mechanistically, and which brain regions is the drug actually acting on?

Asked 26 Sept 2024Modified 19 months agoViewed 33k times
53

The phrase "food noise" is used constantly and I have never seen it defined precisely. My own experience of it was extremely specific and I would like to know what it corresponds to physiologically.

What it was, before treatment: a continuous background process, not hunger. I could have just eaten and still be running a low-level evaluation of what was in the kitchen, when the next meal was, whether the bakery was on the way home. It occupied genuine cognitive bandwidth. It was worse when I was tired or stressed and it was almost completely independent of whether I was physically full.

What happened on semaglutide, about eleven days in: it stopped. Not reduced, stopped. The kitchen became furniture. That is a strange enough experience that I want to understand what changed.

Concretely: is food noise a recognised construct with any measurement instrument behind it, or is it a lay term? Which receptor populations does a peripherally administered peptide of this size actually reach, given that it should not cross the blood-brain barrier freely? And is the mechanism the same one that produces satiety and nausea, or are those separate pathways that happen to be triggered by the same molecule?

food-noise
food-noise

The reduction in intrusive, appetitive thinking about food that most people on the class describe. Its likely basis in central GLP-1R signalling,…

14 questions
glp1-mechanism
glp1-mechanism

Receptor-level pharmacology: GLP-1R as a class B GPCR, cAMP and PKA signalling, biased agonism, internalisation and resensitisation, and the…

175 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questions
ecnoglutide
ecnoglutide

A long-acting GLP-1 receptor agonist with a cAMP-biased signalling profile. A niche tag, mostly used for mechanism questions about biased agonism…

14 questions
shareeditfollowflag
FU
askedforty_units14k1726 Sept 2024
4The distinction you draw between this and hunger is the important one and it maps onto separate circuitry. – e_dziedzic 7 months ago
3There is a validated instrument used in the semaglutide programme, though it does not use the phrase "food noise". – Dr_Jonas_Halvorsen 5 months ago
add a comment

3 Answers

Accepted answer first, then by votes
168

Accepted answer

Food noise is a lay term for something with a reasonable scientific analogue: incentive salience of food cues, sometimes framed as hedonic hunger or cue reactivity. It is separable from homeostatic hunger both experientially and anatomically, which is why your description of it being independent of fullness is not a quirk of introspection but an accurate report.

Is it measured?

Yes, imperfectly, and the semaglutide programme did measure it. The instrument used was the Control of Eating Questionnaire, which scores craving control, craving for sweet and savoury foods, positive mood and hunger as separate domains. In the trial analyses using it, semaglutide improved craving control and reduced craving intensity separately from its effect on hunger [1]. Other instruments in the wider literature include the Power of Food Scale and various food-craving questionnaires. None of them are called "food noise" and none capture the intrusive, involuntary-thought quality you describe particularly well, which is a genuine gap.

How a peptide that size reaches the brain

It largely does not cross the blood-brain barrier by diffusion. It does not need to. There are three routes and all three matter:

  1. Circumventricular organs, which lack a tight barrier by design because their job is to sample the blood. The area postrema and the subfornical organ are directly accessible to circulating peptide.
  2. Vagal afferents, whose terminals in the gut wall express the receptor and project to the nucleus tractus solitarius. This is an indirect, neural route rather than a chemical one.
  3. Limited direct access to circumscribed brain regions. Rodent work tracing labelled semaglutide found uptake in specific hypothalamic and brainstem regions rather than diffusely, with downstream activation propagating to areas the drug itself never reached [2].

That third point is the key architectural fact: the drug binds in a few accessible places, and the effect spreads through existing neural circuitry. So you should not expect the receptor map and the effect map to coincide.

The regions and what each one does

RegionReceptor populationDirect access to circulating drugFunctional contributionSubjective correlate
Hypothalamic arcuate nucleusGLP-1R on POMC/CART neurons; AgRP/NPY neurons inhibited indirectly via local GABAergic signallingPartial, via median eminence proximityPrimary hypothalamic mediator of the weight effect; this population was shown to be necessary for the effect of a GLP-1 agonist in rodents [3]Reduced drive to eat; earlier and more durable satiation
Area postremaDense GLP-1RYes, circumventricularChemoreceptive trigger zone for emesis; also contributes to meal terminationNausea, vomiting, food aversion
Nucleus tractus solitariusGLP-1R plus the brain's own preproglucagon neurons, which are the endogenous central source of GLP-1Partial; also receives vagal inputIntegrates gut signals with hypothalamic and forebrain outputFullness, meal-size limitation
Paraventricular nucleusGLP-1RIndirectAutonomic and neuroendocrine output; stress-eating interactionsReduced stress-driven intake in some reports
Ventral tegmental area and nucleus accumbensGLP-1R, at lower densityLargely indirectMesolimbic dopamine signalling; assigns incentive salience to cuesThis is the food-noise circuit. Reduced wanting, reduced cue-triggered seeking
Amygdala and insulaGLP-1R and downstream activationIndirectAffective valuation of food; interoceptionFood becomes less emotionally loaded
Subfornical organGLP-1RYes, circumventricularFluid balance and thirst regulationAltered thirst reported by some
Vagal afferent terminals (peripheral)GLP-1R on nodose ganglion neuronsYes, peripheralGut-to-brain signalling; also mediates delayed gastric emptyingFullness, early satiation, reflux

Answering your third question directly: separate pathways

Yes, and this is the most practically important thing in the whole topic. Human imaging work with GLP-1 receptor activation showed changes in responses to food cues in reward-related regions including the insula, amygdala, orbitofrontal cortex and putamen, and those changes were separable from the gastrointestinal effects [4].

Three effects, three substrates:

  • Reduced incentive salience (the food-noise effect): mesolimbic, arcuate-mediated downstream. Persistent, dose-dependent, and it does not require any GI symptom.
  • Delayed gastric emptying and early satiation: peripheral vagal plus brainstem. Substantially tachyphylactic, meaning it diminishes over weeks to months of continued exposure.
  • Nausea and aversion: area postrema. Also tachyphylactic, which is why side effects fade.

The fact that the second and third diminish over time while the first largely does not explains a great deal of what people report, including the question two answers below about whether returning food noise means tolerance. If someone's "quiet" was mostly aversion, it goes away on the normal side-effect timeline. If it was mostly reduced salience, it tends to persist.

On your eleven-day onset

That timing fits the pharmacokinetics well. With a roughly one-week half-life you approach steady state over four to five weeks, but you cross the threshold for a noticeable central effect much earlier, and eleven days is around two half-lives, i.e. about 75% of the way to your first steady state. The abruptness people report, the sense that it switched off rather than faded, is consistent with a threshold effect in a circuit rather than a linear dose-response in a symptom.

edited 16 Dec 2024 by lane_transit — removed a claim I could not source

shareimprove this answerflag
LT
answered · acceptedlane_transit42k3814 Dec 2024
The three-pathways framing is the most useful thing I have read on this, particularly the point that two of the three are tachyphylactic and one is not. – kirsi_lahtinen 3 months ago
Worth stressing that the arcuate work was done in rodents with receptor knockdowns. The human evidence is imaging and inference. – tri_gly_ala 2 months ago
3The "kitchen became furniture" description in the question is a better phenomenological account than most of the instruments capture. – mz_4113 8 days ago
add a comment
Sponsored

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample
Sponsored — paired listing

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem
62

Adding the conceptual distinction that makes the anatomy easier to hold onto, because it comes from a well-established framework in addiction neuroscience rather than from obesity research.

Reward has separable components:

  • Wanting, or incentive salience: the motivational pull a cue exerts. Dopaminergic, mesolimbic, and it can be enormous while pleasure is modest.
  • Liking, or hedonic impact: how pleasant the thing actually is when consumed. Opioid and endocannabinoid systems, anatomically distinct hedonic hotspots.
  • Learning: the predictive associations that make a cue meaningful in the first place.

Food noise is a wanting phenomenon. That is why it is independent of fullness, why it responds to cues rather than to energy state, and why it can feel intrusive and unwelcome rather than pleasurable. It is also why the most common report on these drugs is not "food tastes bad" but "I can see the cake and simply not care", which is reduced wanting with liking left intact.

Two predictions this framework makes, both of which match what people report:

  1. People will still enjoy food they eat, sometimes more, because they eat it deliberately rather than compulsively. Reduced wanting with preserved liking.
  2. The effect will generalise to other cue-driven appetitive behaviours, because the substrate is not food-specific. That is exactly what the alcohol and nicotine reports look like.

Where it does not fit neatly: a subset of people describe genuine changes in taste and in liking, particularly aversion to fat, to alcohol and to the smell of cooking meat. That is more consistent with a conditioned taste aversion mechanism via the area postrema than with reduced wanting, which is another argument for treating those two effects as separate phenomena that happen to share a drug.

shareimprove this answerflag
MO
answeredmarta_okonkwo87k2583 Dec 2024
3The wanting/liking distinction should be the first thing anyone reads about this. It resolves most of the confused reports. – bac_or_bust 7 months ago
add a comment
27

Worth adding a caution about how easily this topic slides into over-confident mechanism talk, because the honest epistemic position is narrower than the table above might suggest.

What is well established: the receptor distributions, that the arcuate population is necessary for the weight effect in rodent models, that human imaging shows altered responses to food cues in reward regions, and that the clinical effect on craving measures is real and reproducible in randomised trials.

What is inference rather than demonstration:

  • That the mesolimbic receptor population is the specific substrate of the subjective experience people call food noise. Plausible, consistent with imaging, not directly shown.
  • That the intrusive-thought quality of food noise corresponds to a distinct neural process rather than being one end of a continuum of appetitive drive.
  • Most of the region-by-region attribution of subjective effects. Assigning "reduced emotional loading of food" to the amygdala is a reasonable guess informed by what that region does generally, not a finding.
  • Almost all cross-species extrapolation. Rodents do not report intrusive thoughts about bakeries.

The reason to be careful is not pedantry. It is that confident mechanistic stories get used to justify confident predictions, for instance that a particular molecule will or will not affect food noise based on its receptor profile, or that a returning effect must indicate receptor-level tolerance. Those predictions frequently fail. The phenomenology is well described, the pharmacology is well described, and the mapping between them is partially guessed.

shareimprove this answerflag
TU
answeredtenth_of_a_unit40k385 Jan 2025

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.